Therapeutic administration of bone marrow‐derived mesenchymal stromal cells reduces airway inflammation without up‐regulating Tregs in experimental asthma
Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2222|48|2|205-216
ISSN: 0954-7894
Source: CLINICAL & EXPERIMENTAL ALLERGY, Vol.48, Iss.2, 2018-02, pp. : 205-216
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract